Literature DB >> 27790422

P3 Fraction: Effect on HbA1c Values by HPLC.

Mrinal Gupta1, Mohit Thalquotra2, Pragna Rao3.   

Abstract

INTRODUCTION: The availability of the haemoglobin A1c test has been a major advance in diabetic care and its measurement has become an integral part for the management of diabetes. When glycated haemoglobin (HbA1c) is estimated by High Performance Liquid Chromatography (HPLC), one of the fractions that are eluted is known as "P3" fraction which is labelled as "degenerated haemoglobin". The P3 fraction is not taken into account while estimating HbA1c or HbA values. AIM: To study the effect of P3 on the final reported value of HbA1c by HPLC and the significance of this fraction in the final chromatogram. The possibility that HbA1c fraction is under reported due to increase in P3 fraction was also examined.
MATERIALS AND METHODS: HbA1c, various fractions of HbA1 and P3 were estimated by HPLC method in 430 subjects. Patient data was divided into 3 groups on the basis of HbA1c% (group I - <6%, group II - 6 - 12%, group III - >12%). RESULT: P3% as well as P3 area increases as the HbA1c increases (p-value - <0.001). Statistical significant increase was seen as HbA1c% increases, P3% also increases and correlation (r = 0.6) became stronger with increasing HbA1c levels. HbA1a%, HbA1b% fraction increases with increase in HbA1c% and HbA1a area, HbA1b area also shows the same increase with increasing HbA1c%.
CONCLUSION: From this study we conclude that sub fractions of glycated haemoglobin and P3 fraction influence the final reported value of HbA1c by HPLC. P3 fraction might indicate the possible presence of variant haemoglobin in the sample.

Entities:  

Keywords:  Glycated haemoglobin; HbA1a%; HbA1b%; Variant haemoglobins

Year:  2016        PMID: 27790422      PMCID: PMC5071922          DOI: 10.7860/JCDR/2016/21092.8451

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  13 in total

1.  IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study.

Authors:  Wieland Hoelzel; Cas Weykamp; Jan-Olof Jeppsson; Kor Miedema; John R Barr; Ian Goodall; Tadao Hoshino; W Garry John; Uwe Kobold; Randie Little; Andrea Mosca; Pierluigi Mauri; Rita Paroni; Fransiscus Susanto; Izumu Takei; Linda Thienpont; Masao Umemoto; Hsiao-Mei Wiedmeyer
Journal:  Clin Chem       Date:  2004-01       Impact factor: 8.327

2.  HPLC retention time as a diagnostic tool for hemoglobin variants and hemoglobinopathies: a study of 60000 samples in a clinical diagnostic laboratory.

Authors:  Alla Joutovsky; Joan Hadzi-Nesic; Michael A Nardi
Journal:  Clin Chem       Date:  2004-10       Impact factor: 8.327

Review 3.  Clinical significances of superoxide dismutases: changes in aging, diabetes, ischemia, and cancer.

Authors:  N Taniguchi
Journal:  Adv Clin Chem       Date:  1992       Impact factor: 5.394

4.  Effects of sample storage conditions on glycated hemoglobin measurement: evaluation of five different high performance liquid chromatography methods.

Authors:  Randie R Little; Curt L Rohlfing; Alethea L Tennill; Shawn Connolly; Steve Hanson
Journal:  Diabetes Technol Ther       Date:  2007-02       Impact factor: 6.118

5.  Autoxidation reactions of hemoglobin A free from other red cell components: a minimal mechanism.

Authors:  J A Watkins; S Kawanishi; W S Caughey
Journal:  Biochem Biophys Res Commun       Date:  1985-10-30       Impact factor: 3.575

Review 6.  A review of the challenge in measuring hemoglobin A1c.

Authors:  Cas Weykamp; W Garry John; Andrea Mosca
Journal:  J Diabetes Sci Technol       Date:  2009-05-01

7.  Silent hemoglobin variants and determination of HbA(1c) with the high-resolution program of the HPLC HA-8160 hemoglobin analyzer.

Authors:  Wolfgang J Schnedl; Theresa Lahousen; Sandra J Wallner; Robert Krause; Rainer W Lipp
Journal:  Clin Biochem       Date:  2005-01       Impact factor: 3.281

8.  Effect of iron deficiency on glycation of haemoglobin in nondiabetics.

Authors:  Balasubramanian Shanthi; Carnagarin Revathy; Arcot Jagdeeshwaran Manjula Devi
Journal:  J Clin Diagn Res       Date:  2012-09-18

9.  Reduced vitamin E and increased lipofuscin products in erythrocytes of diabetic rats.

Authors:  S K Jain; S N Levine; J Duett; B Hollier
Journal:  Diabetes       Date:  1991-10       Impact factor: 9.461

10.  Silent haemoglobin variants and determination of HbA(1c) with the HPLC Bio-Rad Variant II.

Authors:  T Lahousen; R E Roller; R W Lipp; W J Schnedl
Journal:  J Clin Pathol       Date:  2002-09       Impact factor: 3.411

View more
  1 in total

1.  Type 2 Diabetes Mellitus with HbJ trait: A management conundrum.

Authors:  Wan Natrah Wan Yaacob; Lili Husniati Yaacob; Nani Draman
Journal:  Malays Fam Physician       Date:  2022-03-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.